Workboat Indexes

Kuros Bioscience Ltd (OP: CSBTF )

13.70 UNCHANGED

Streaming Delayed Price Updated: 9:31 AM EDT, Jul 16, 2024 Add to My Watchlist

Price and Volume

Volume	0
Open	13.70
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	13.70
Today's Range	13.70 - 13.70
52wk Range	2.130 - 14.20
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 Study Outcomes in Spine, Indicating Superiority Over Autograft

June 25, 2024

Via ACCESSWIRE

Kuros Reports Corporate Highlights as of Q1 2024 Including Increase in Direct MagnetOsTM Sales

April 23, 2024

Via ACCESSWIRE

Performance

YTD	+186.01%	+186.01%
1 Month	-2.49%	-2.49%
3 Month	+64.47%	+64.47%
6 Month	+166.02%	+166.02%
1 Year	+543.19%	+543.19%

More News

Annual General Meeting of Kuros Biosciences Approves All Resolutions

April 17, 2024

Via ACCESSWIRE

Kuros Reports 163% Growth in Direct MagnetOs Sales and 153% Increase in Total Medical Device Sales for the Full Year 2023

March 12, 2024

Via ACCESSWIRE

Kuros Biosciences to Report Full Year Financial Results for 2023 and Provide Corporate Update

March 07, 2024

Via ACCESSWIRE

Kuros Biosciences to Present at the CG 2024 Musculoskeletal Conference

January 31, 2024

Via ACCESSWIRE

Kuros Biosciences Receives US FDA 510K Clearance for MagnetOs Granules for Interbody Use and Regulatory Clearance of MagnetOs Granules and MagnetOs Putty in New Zealand

January 30, 2024

Via ACCESSWIRE

Kuros Biosciences Announces Three Advancements Related to its MagnetOsTM Portfolio Including Impressive Fusion Data from MAXA Prospective Randomized Clinical Trial and Two 510(k) Clearances from FDA

January 03, 2024

Via ACCESSWIRE

Kuros Biosciences Announces Results from Two Prospective Randomized Clinical Trials: STRUCTURE and MAXA

December 26, 2023

Via ACCESSWIRE

Kuros Biosciences Receives FDA Clearance for Use of MagnetOs in Interbody Spinal Cages

November 28, 2023

Via ACCESSWIRE

Kuros Reports a 150% Increase in Direct MagnetOs Sales in the First Nine Months of 2023 and Announces Changes Within the Executive Management

October 12, 2023

Via ACCESSWIRE

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.